Smoking cessation: What works?

Australian Family Physician

Volumn 37, Issue 1-2, 2008, Pages 10-14

  Zwar, Nicholas ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b General Practice Unit   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAZEPINE DERIVATIVE; QUINOXALINE DERIVATIVE; VARENICLINE;

ARTICLE; AUSTRALIA; COUNSELING; EVIDENCE BASED MEDICINE; FEMALE; GENERAL PRACTICE; HUMAN; MALE; METHODOLOGY; PHYSICIAN ATTITUDE; PSYCHOLOGICAL ASPECT; SMOKING; SMOKING CESSATION;

AUSTRALIA; BENZAZEPINES; COUNSELING; EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; FEMALE; HUMANS; MALE; PHYSICIAN'S ROLE; QUINOXALINES; SMOKING; SMOKING CESSATION;

EID: 40649115994     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Australian Institute of Health and Welfare 2006. Australia's health 2006. AIHW cat. no. AUS 73. Canberra: AIHW, 158.
2. Australian Institute of Health and Welfare 2005. 2004 National drug strategy household survey: detailed findings. AIHW cat. no. PHE 66. Canberra: AIHW, 2005.
3. Owen N, Wakefield M, Roberts L, Esterman A. Stages of readiness to quit smoking: population prevalence and correlates. Health Psychol 1992;11:413-7.
4. Lancaster T, Stead LF. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD000165.
5. Fiore MC, Bailey WC, Cohen SJ, et al for the Guideline Panel. Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: US Department of Health and Human Services, 2000.
6. The COMMIT Research Group. Community Intervention Trial for Smoking Cessation (COMMIT): II Changes in adult cigarette smoking prevalence. Am J Pub Health 1995;85:193-200.
7. Litt J, Ling M-Y, McAvoy B. How to help your patients quit: practice based strategies for smoking cessation. Asia Pacific Fam Med 2003;2:175-9.
8. Young JM, Ward JE. Implementing guidelines for smoking cessation advice in Australian general practice: opinions, current practices, readiness to change and perceived barriers. Fam Pract 2001;18:14-20.
9. Prochaska JO, Velicer WF. The transtheoretical model of health behaviour change. Am J Health Promot 1997;12:38-48.
10. West R, Sohal T. 'Catastrophic' pathways to smoking cessation: findings from national survey. BMJ 2006;332:458-6.
11. Zwar N, Richmond R, Borland R, Stillman S, Cunningham M, Litt J. Smoking cessation guidelines for Australian general practice. Practice handbook, 2004 edn. Canberra: Australian Government Department of Health and Ageing, 2004.
12. Richmond RL, Austin A, Webster IW. Three year evaluation of a programme by general practitioners to help patients stop smoking. BMJ 1986;292:803-6.
13. Richmond RL, Mackinson RJ, Kehoe LA, Giugni AA, Webster IW. One-year evaluation of three smoking cessation interventions administered by general practitioners. Addict Behav 1993;18:187-99.
14. Silagy C, Mant D, Fowler G, Lancaster T. The Cochrane Library, Issue 2. Oxford: Update Software, 1998. Nicotine replacement therapy for smoking cessation. Database of abstracts of reviews of effectiveness.
15. Hughes JR, Stead LF, Lancaster TR. The Cochrane Library, Issue 2. Oxford: Update Software, 1998. Anxiolytics and antidepressants in smoking cessation. Database of abstracts of reviews of effectiveness.
16. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD006103.
17. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD000031.
18. Varenicline for smoking cessation. NICE technology appraisal guidance 123, 2007 Available at www.nice.org.uk/TA123.
19. Wu P, Wilson K, Dimoulas P, Mills E. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health 2006;6:300.
20. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist vs sustained-release bupropion and placebo for smoking cessation. J Am Med Assoc 2006;296:47-55.
21. Jorenby DE, Taylor Hays J, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist vs placebo or sustained-release bupropion for smoking cessation. J Am Med Assoc 2006;296:56-63.
22. Tonstad S, Tonnesen P, Hajek P, et al. Effect of maintenance therapy with varenicline on smoking cessation. J Am Med Assoc 2006;296:64-71.
23. Guidelines for healthcare professionals on using nicotine replacement therapy for smokers not yet ready to stop smoking. ASH February 2007. Available at www.ashaust.org.au.
24. National Institute for Clinical Excellence. Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. Technology Appraisal Guidance No. 39. March 2002. Available at www.nice.org.uk.
25. Richmond R, Zwar N. Therapeutic review of bupropion sustained release. Aust Drug Alcohol Rev 2003;22:203-20.
26. Evins AE, Cather C, Deckersbach T, et al. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol 2005;25:218-25.
27. Hughes JR, Lindsay F, Stead LF, Lancaster T. Nortriptyline for smoking cessation: a review. Nicotine Tob Res 2005;7:491-9.
28. Ministry of Health. New Zealand smoking cessation guidelines. Wellington: Ministry of Health, 2007. Available at www.health.gov.au/ internet/wcms/publishing.nsf/content/ health-pubhlth-publicat-document-smokingşsation-cnt.htm.
29. White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking cessation. Cochrane Database of Systematic Reviews 2006 Art. No.: CD000009.
30. Abbot, Stead LF, White AR, Barnes J. Hypnotherapy for smoking cessation. Cochrane Database of Systematic Reviews 1998 Art. No.: CD001008.
31. McRobbie H, Hayek, P, Bullen C, Feigin V. Rapid review on non-NHS treatments for smoking cessation. 2 February 2007. Available at http://guidance.nice.org.uk.